mecbotamab vedotin (BA3011)

News alerts, weekly reports and conference planners

Company:

BioAtla

Drug class:

Microtubule inhibitor, AXL-targeted antibody-drug conjugate

AXL expression	Prostate Cancer	AXL expression	Prostate Cancer	BA3011 Sensitive: D – Preclinical BA3011 Sensitive : D	BA3011 Sensitive: D – Preclinical BA3011 Sensitive : D
AXL expression	Pancreatic Cancer	AXL expression	Pancreatic Cancer	BA3011 Sensitive: D – Preclinical BA3011 Sensitive : D	BA3011 Sensitive: D – Preclinical BA3011 Sensitive : D
AXL expression	Lung Cancer	AXL expression	Lung Cancer	BA3011 Sensitive: D – Preclinical BA3011 Sensitive : D	BA3011 Sensitive: D – Preclinical BA3011 Sensitive : D

Associations
(3)